Ludvik B, Fras JP, Tinahones FJ, et al
In a rigorous 6-week, double-blind, placebo-controlled clinical trial published in the Aesthetic Surgery Journal Open Forum, DermaReverse demonstrated remarkable results among GLP-1 users: 100% of participants experienced an improvement in wrinkle appearance 100% experienced an improvement in surface roughness 100% experienced a reduction in redness 100% experienced an improvement in hydration 100% agreed DermaReverse was gentle enough for daily use These results were verified by independent board-certified plastic surgeons and third-party independent medical journal reviewers, establishing DermaReverse as not just another skincare product, but a clinically validated treatment specifically addressing the unique skin concerns of GLP-1 users
The number of melanocytes (pigment-generating cells) decreases, causing the skin's antioxidant system to drop
These side effects may have compromised further development of the product [3]
"Im happier, Im more energetic, and there's no question I'm healthier."